Amler; Lukas C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Amler; Lukas C..The latest application filed is for "genetic variations associated with drug resistance".

Company Profile

1.7.15

Amler; Lukas C. - Foster City CA
Amler; Lukas C. - Pennington NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Genetic variations associated with drug resistance Grant 11,021,711 - Lackner , et al. June 1, 2	2021-06-01
Genetic Variations Associated With Drug Resistance App 20180298387 - Lackner; Mark ; et al.	2018-10-18
Genetic variations associated with drug resistance Grant 9,879,267 - Lackner , et al. January 30, 2	2018-01-30
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab App 20160175438 - Alavattam; Sreedhara ; et al.	2016-06-23
Predicting Response To A Her Inhibitor App 20150111211 - Amler; Lukas C. ; et al.	2015-04-23
Predicting response to a HER inhibitor Grant 8,940,302 - Amler , et al. January 27, 2	2015-01-27
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab App 20130095172 - Alavattam; Sreedhara ; et al.	2013-04-18
Predicting Response To A Her Inhibitor App 20130039909 - Amler; Lukas C. ; et al.	2013-02-14
Predicting Response To A Her Inhibitor App 20110245103 - Amler; Lukas C. ; et al.	2011-10-06
Predicting Response To A Her Inhibitor App 20110246399 - AMLER; LUKAS C. ; et al.	2011-10-06
Genetic Variations Associated With Drug Resistance App 20110177099 - Lackner; Mark ; et al.	2011-07-21
Predicting response to a HER inhibitor Grant 7,981,418 - Amler , et al. July 19, 2	2011-07-19
Predicting response to a HER inhibitor App 20100008975 - Amler; Lukas C. ; et al.	2010-01-14
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells Grant 7,537,891 - Huang , et al. May 26, 2	2009-05-26
Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells Grant 7,504,211 - Huang , et al. March 17, 2	2009-03-17
Selecting Patients For Therapy With A Her Inhibitor App 20080317753 - AMLER; LUKAS C. ; et al.	2008-12-25
Extending survival of cancer patients with elevated levels of EGF or TGF-alpha App 20080038271 - Amler; Lukas C. ; et al.	2008-02-14
Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators App 20060234237 - Amler; Lukas C. ; et al.	2006-10-19
Selecting patients for therapy with a her inhibitor App 20060121044 - Amler; Lukas C. ; et al.	2006-06-08
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells App 20060029944 - Huang; Fei ; et al.	2006-02-09
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells App 20040106132 - Huang, Fei ; et al.	2004-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.